HomeDTC • FRA
add
Defence Therapeutics Inc
Previous close
€0.79
Day range
€0.76 - €0.81
Year range
€0.32 - €1.31
Market cap
53.37M CAD
Avg Volume
23.12K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Investing.com
2 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.08%
2.08%
5.07%
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 590.64K | -92.88% |
Net income | -804.84K | 90.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -579.59K | 93.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 130.52K | -62.81% |
Total assets | 403.03K | -39.74% |
Total liabilities | 3.86M | 30.11% |
Total equity | -3.45M | — |
Shares outstanding | 54.73M | — |
Price to book | -11.34 | — |
Return on assets | -356.79% | — |
Return on capital | 66.38% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -804.84K | 90.33% |
Cash from operations | -668.38K | — |
Cash from investing | 18.60K | — |
Cash from financing | 649.10K | — |
Net change in cash | -677.00 | — |
Free cash flow | -387.29K | -123.56% |
About
Founded
2017
Headquarters
Website
